Business Description
Saroja Pharma Industries India Ltd
ISIN : INE0PCL01011
Total Employee Number:
12Compare
Compare
Traded in other countries / regions
SAROJA.India IPO Date
2023-09-13Description
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.6 | |||||
Debt-to-EBITDA | 3.4 | |||||
Interest Coverage | 2.2 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.27 | |||||
Beneish M-Score | -2.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.2 | |||||
3-Year EBITDA Growth Rate | 6.7 | |||||
3-Year EPS without NRI Growth Rate | -3.3 | |||||
3-Year FCF Growth Rate | 28.7 | |||||
3-Year Book Growth Rate | 57.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 72.91 | |||||
9-Day RSI | 76.88 | |||||
14-Day RSI | 75.87 | |||||
3-1 Month Momentum % | -7.69 | |||||
6-1 Month Momentum % | -6.4 | |||||
12-1 Month Momentum % | -37.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 1.21 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 1.86 | |||||
Days Sales Outstanding | 145.45 | |||||
Days Payable | 72.35 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 9.59 | |||||
Operating Margin % | 4.98 | |||||
Net Margin % | 1.93 | |||||
EBITDA Margin % | 5.17 | |||||
FCF Margin % | -2.69 | |||||
OCF Margin % | 2.14 | |||||
ROE % | 6.82 | |||||
ROA % | 3.13 | |||||
ROIC % | 8.28 | |||||
3-Year ROIIC % | 2.67 | |||||
ROC (Joel Greenblatt) % | 12.07 | |||||
ROCE % | 15.53 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.45 | |||||
PE Ratio without NRI | 15.45 | |||||
PS Ratio | 0.3 | |||||
PB Ratio | 1.02 | |||||
Price-to-Tangible-Book | 1.05 | |||||
Price-to-Operating-Cash-Flow | 13.9 | |||||
EV-to-EBIT | 9.6 | |||||
EV-to-EBITDA | 9.2 | |||||
EV-to-Revenue | 0.48 | |||||
EV-to-FCF | -17.35 | |||||
Price-to-Graham-Number | 0.86 | |||||
| Price-to-Net-Current-Asset-Value | 4.93 | |||||
Earnings Yield (Greenblatt) % | 10.42 | |||||
FCF Yield % | -8.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Saroja Pharma Industries India Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 537.268 | ||
| EPS (TTM) (₹) | 2.57 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 47.96 | ||
| 14-Day RSI | 75.87 | ||
| 14-Day ATR (₹) | 0.934907 | ||
| 20-Day SMA (₹) | 33.0175 | ||
| 12-1 Month Momentum % | -37.3 | ||
| 52-Week Range (₹) | 28 - 51.75 | ||
| Shares Outstanding (Mil) | 4.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Saroja Pharma Industries India Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Saroja Pharma Industries India Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Saroja Pharma Industries India Ltd Frequently Asked Questions
What is Saroja Pharma Industries India Ltd(NSE:SAROJA)'s stock price today?
The current price of NSE:SAROJA is ₹40.95. The 52 week high of NSE:SAROJA is ₹51.75 and 52 week low is ₹28.00.
When is next earnings date of Saroja Pharma Industries India Ltd(NSE:SAROJA)?
The next earnings date of Saroja Pharma Industries India Ltd(NSE:SAROJA) is .
Does Saroja Pharma Industries India Ltd(NSE:SAROJA) pay dividends? If so, how much?
Saroja Pharma Industries India Ltd(NSE:SAROJA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Saroja Pharma Industries India Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers